Chemicals that fall under the class of GIMAP3 Inhibitors are compounds which, through their actions on various signaling pathways and cellular processes, indirectly modulate the activity of the GIMAP3 protein. The chemicals listed target different aspects of cellular signaling, which can consequently affect the regulation and function of GIMAP3. Inhibitors like NSC23766 and ML141 act on Rac1 and Cdc42 GTPases, respectively, which are proteins related to the same superfamily as GIMAP3 and are crucial in the regulation of immune cell function and actin cytoskeleton organization. By altering the activity of these related GTPases, the regulatory role of GIMAP3 within immune responses can be influenced.
SecinH3 and Brefeldin A target other aspects of GTPase regulation, with SecinH3 inhibiting cytohesin proteins that modulate GTPase signaling and Brefeldin A affecting ARF GTPases involved in vesicle trafficking, which could indirectly affect GIMAP3's function in immune responses. The rest of the inhibitors, such as CID755673, ZCL278, LY294002, PD0325901, SB203580, SP600125, Wortmannin, and Y-27632, target various kinases and signaling molecules like PI3K, MEK, p38 MAPK, JNK, and ROCK. These proteins are all participants in signaling cascades that can influence cellular processes such as inflammation, apoptosis, and cell survival, where GIMAP3 may also play a part.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
NSC 23766 | 733767-34-5 | sc-204823 sc-204823A | 10 mg 50 mg | $151.00 $609.00 | 75 | |
Rac1 inhibitor that can disrupt GTPase signaling, affecting GIMAP3-related immune cell regulation. | ||||||
ML 141 | 71203-35-5 | sc-362768 sc-362768A | 5 mg 25 mg | $137.00 $512.00 | 7 | |
Cdc42 inhibitor that can alter GTPase activity, potentially influencing GIMAP3 function in immune responses. | ||||||
SecinH3 | 853625-60-2 | sc-203260 | 5 mg | $278.00 | 6 | |
Cytohesin inhibitor that can impact GTPase signaling, possibly affecting processes involving GIMAP3. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Inhibitor of ADP-ribosylation factor (ARF), can disrupt GTPase function, potentially affecting GIMAP3-mediated pathways. | ||||||
ZCL278 | 587841-73-4 | sc-507369 | 10 mg | $115.00 | ||
Cdc42 inhibitor that can modify GTPase signaling, potentially altering GIMAP3's role in immune regulation. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
PI3K inhibitor that can affect signaling pathways involving GTPases, potentially modulating GIMAP3 function. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
p38 MAPK inhibitor that can modify inflammatory responses, possibly impacting GIMAP3's regulatory role. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
JNK inhibitor that can affect stress and inflammatory response pathways, potentially influencing GIMAP3 activity. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Another PI3K inhibitor that can disrupt GTPase-related signaling, potentially affecting GIMAP3 function. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
ROCK inhibitor that can affect cytoskeletal regulation involving GTPases, potentially influencing GIMAP3. | ||||||